News and Events

Keep up to date with our latest product news, information and events.

NHS trusts evaluate GALEAS Bladder to improve bladder cancer pathway

Nonacus introduces its first ultrasensitive qPCR assay for ESR1 mutation detection

NHS trusts evaluate GALEAS Bladder to improve bladder cancer pathway

January 08, 2025

Nonacus introduces its first ultrasensitive qPCR assay for ESR1 mutation detection

October 31, 2024

Nonacus achieves ISO 27001 certification for GALEAS software

October 22, 2024

Nonacus Awarded All Wales Medical Genomics Service (AWMGS) Tender for Familial Hypercholesterolaemia Testing

Nonacus Awarded All Wales Medical Genomics Service (AWMGS) Tender for Familial Hypercholesterolaemia Testing

September 24, 2024

Nonacus appoints Jeff Bousfield as CEO

Bladder Cancer Awareness Month: a breakthrough for early diagnosis

Read all about it in The Telegraph – the potential of GALEAS Bladder in the early diagnosis of bladder cancer

Precision oncology webinar series: Explore advancements in genomic tumor characterization and clinical application

Nonacus launches test for comprehensive genomic profiling, integrated with bioinformatics and analysis software

New genetic test to speed up and streamline diagnosis of inherited cancers

January 24, 2024

Sign up to receive updates

Leave us your email below to be the first to know when we publish a new blog post.